FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

121074009: Antigen of Bordetella pertussis (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
179661018 Bordetella pertussis antigen en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3782914010 Antigen of Bordetella pertussis (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3782915011 Antigen of Bordetella pertussis en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3783232010 Bordetella pertussis Ag en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
73131000087112 antigène coquelucheux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bordetella pertussis antigen Is a Bacteria antigen false Inferred relationship Some
Bordetella pertussis antigen Causative agent (attribute) Bordetella pertussis false Inferred relationship Some
Bordetella pertussis antigen Is a Bordetella Ag true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Bordetella pertussis antigen assay (procedure) Has measured component (attribute) False Bordetella pertussis antigen Inferred relationship Some
Bordetella pertussis antigen assay (procedure) Component True Bordetella pertussis antigen Inferred relationship Some 1
Antigen of acellular Bordetella pertussis (substance) Is a True Bordetella pertussis antigen Inferred relationship Some
Antigen of whole cell Bordetella pertussis (substance) Is a True Bordetella pertussis antigen Inferred relationship Some
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 1
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 1
Bordetella pertussis antigen-containing vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 1
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 2
Bordetella pertussis antigen only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 1
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 1
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 1
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 1
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 1
Vaccine product containing Bordetella pertussis and Clostridium tetani toxoid and Corynebacterium diphtheriae toxoid and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bordetella pertussis antigen Inferred relationship Some 2
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus and Measles morbillivirus antigens only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 2
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Bordetella pertussis antigen Inferred relationship Some 1

This concept is not in any reference sets

Back to Start